The S&P 500 soared more than 32% in 2013, and several big pharma companies, namely Bristol-Myers Squibb (NYSE:BMY), AbbVie (NYSE:ABBV), Roche (OTC:RHHB.Y), Johnson & Johnson (NYSE:JNJ), and AstraZeneca (NYSE:AZN) also performed extraordinarily well. The following slideshow reveals why these companies beat out their big pharma peers and what drove their strong performances in 2013.
The 5 Best-Performing Big Pharma Stocks of 2013: BMY, ABBV, RHHBY, JNJ, AZN
The pharmaceutical sector had a stellar 2013, but which stocks were the best?
Max Macaluso
(TMFMassimo)
Jan 6, 2014 at 6:30PM
Author Bio
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo
Motley Fool Returns
Stock Advisor
S&P 500
481%
100%
Stock Advisor launched in February of 2002. Returns as of 09/21/2020.
Join Stock Advisor
Cumulative Growth of a $10,000 Investment in Stock Advisor
Calculated by Time-Weighted Return
Stocks
RHHB.Y
